Herbert Loong: Beung Chul Ahn’s insights on 2nd-line management of EGFR-positive patients

Herbert Loong, Chair of the International Affairs Committee at American Society of Clinical Oncology (ASCO), shared a post on X:

“Next up is Dr. Beung Chul Ahn from National Cancer Center Korea, providing his experience and insights in management of EGFR-positive patients in the 2nd line setting.”